Anticancer peptide from Chinese toad (Bufo Bufo Gargarizans) skin enhanced sensitivity to 5-Fu in hepatocarcinoma cells (HepG2)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Duellman WE, Trueb L. Biology of Amphibians. New York: McGraw-Hill 1986; 241–260.
Das M, Dasgupta SC, Gomes A. Toad (Bufo melanostictus, Schneider) skin extract induced haematological and biochemical changes in rodents. Indian J Pharmacol 1998a; 30: 68–72.
Das M, Dasgupta SC, Gomes A. Immunomodulatory and antineoplastic activity of common Indian toad (Bufo melanostictus, Schneider) skin extract. Indian J Pharmacol 1998; 30: 311–317.
Ellerby HM, Arap W, Ellerby LM, et al. Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med 1999; 5: 1032–1038.
Mai JC, Mi Z, Kim SH, et al. A proapoptotic peptide for the treatment of solid tumours. Cancer Res 2001; 61: 7709–7712.
Cruciani RA, Barker JL, Zasloff M, et al. Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. Proc Natl Acad Sci 1991; 88: 3792–3796.
Johnstone SA, Gelmon K, Mayer LD, et al. In vitro characterizationof the anticancer activity of membraneactive cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and Pglycoprotein over-expressing tumour cell lines. Anticancer Drug Des 2000; 15: 151–160.
Kawada K, Yonei T, Ueoka H, et al. Comparison of chemosensitivity tests: clonogenic assay versus MTT assay. Acta Med Okayama 2002; 56: 129–134.
Zhang L, Nakaya K, Yoshida T, et al. Bufalin as a potent inducer of differentialion of human myeloid leukemia cells. Biochem Biophys Res Commun 1991; 178: 686–693.
Zhang L, Nakaya K, Yoshida T, et al. Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. Cancer Res 1992; 52: 4634–4641.
Kamano Y, Kotake A, Hashima H, et al. Structurecytotoxic activity relationship for the toad poison bufadienolides. Bioorg Med Chem 1998; 6: 1103–1115.
Lam MH, Liu Q, Elledge SJ, et al. Chk1 is haploinsufficient for multiple functions critical to tumor suppression. Cancer Cell 2004; 6: 45–59.
Yamamura Y, Lee WL, Goh MX, et al. Role of TAp73alpha in induction of apoptosis by transforming growth factorbeta in gastric cancer cells. FEBS Lett 2008; 582: 2663–2667.
Kurokawa M, Zhao C, Reya T, et al. Inhibition of apoptosome formation by suppression of Hsp90beta phosphorylation in tyrosine kinase-induced leukemias. Mol Cell Biol 2008; 28: 5494–5506.
Kim R, Emi M, Tanabe K.The role of apoptosis in cancer cell survival and therapeutic outcome. Cancer Biol Ther 2006; 5: 1429–1442.
Numazawa S, Shinoki MA, et al. Involvement of Na+, K+-ATPase inhibition in K562 cell differentiation induced by bufalin. J Cell Physiol 1994; 160: 113–120.
Han KQ, Huang G, Gu W, et al. Anti-tumour activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumour model of human hepatocellular carcinoma in nude mice. World J Gastroenterol 2007; 13: 3374–3379.
Lee DY, Yasuda M, Yamamoto T, et al. Bufalin inhibits endothelial cell proliferation and angiogenesis in vitro. Life Sci 1997; 60: 127–134.
Akiyama M, Ogura M, Iwai M, et al. Effect of bufalin on growth and differentiation of human skin carcinoma cells in vitro. Hum Cell 1999; 12: 205–209.
Yeh JY, Huang WJ, Kan SF, et al. Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate 2003; 54: 112–124.
Chen Y, Xu C, Hong S, et al. RGD-tachyplesin inhibits tumour growth. Cancer Res 2001; 61: 2434–2438.
Risso A, Braidot E, Sordano MC, et al. BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore. Mol Cell Biol 2002; 22: 1926–1935.
Brueggemeier RW, Su B, Darby MV, et al. Selective regulation of aromatase expression for drug discovery. J Steroid Biochem Mol Biol 2010; 118: 207–210.